SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Therapeutic Advances in Neurological Disorders
The 50 Most-Frequently Cited Articles
in Therapeutic Advances in Neurological Disorders as of November 1, 2009 -- updated monthly

Most-cited rankings are recalculated at the beginning of the month.
Rankings are based on citations to articles on this journal site from articles in HighWire-hosted journals.

1.  Michael K. Racke, Olaf Stüve
Natalizumab: increased vigilance is required in treating patients with multiple sclerosis
Nov 01, 2008; 1: 155-156.
(In "Article")   [PDF]
 
2.  J. Theodore Phillips, Elliot M. Frohman
Natalizumab: benefit outweighs risk in selected patients with multiple sclerosis
Nov 01, 2008; 1: 151-153.
(In "Article")   [PDF]
 
  
rss gif Subscribe to Most Cited feed

Last Updated: 11/09/2009 12:37:25

Advertisement